IP Implications of the Consolidated Appropriations Act, 2021
IP Implications of the Consolidated Appropriations Act, 2021 Thursday, January 14, 2021 On December 27, 2020, Congress signed the Consolidated Appropriations Act, 2021, into law. The omnibus act includes new legislation affecting patent, copyright and trademark law. A brief summary of key provisions is provided below. Patents – Section 325 Biological Product Patent Transparency 42 USC § 262(k) was amended to require that the US Food and Drug Administration (FDA) provide the public with more information about patented biological products. Within six months, the FDA must make the f...
Source: natlawreview.com